LifeMine Therapeutics
Develops fungal genome-derived therapeutics for organ transplant rejection
$263MSeries D+Series E
Role not disclosedBE
Bezos Expeditions
Activity from announced rounds
Activity in this selectionUnited States · Oct 23, 2026 · Jan 1, 2026
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $2.4B 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionOratomic
Builds quantum computers using lasers to hold individual atoms in place
$300MSeries A
Role not disclosedGeneralist AI
Generalist AI develops foundation models that let robots learn tasks across different hardware and environments.
$400MSeries B
ParticipantSkild AI
Building a unified robotics foundation model for controlling robots
$1.4BUndisclosed
Role not disclosed